Hospital Del Mar — Clinical Trial Site

480 Registered trials

196 Currently recruiting

Organisation

Hospital Del Mar

Location

Barcelona, Spain

Identifier

ORG-100028631

Address

Passeig Maritim De La Barceloneta 25-29, 08003, Spain

Departments

-
#034016 Oncología Médica
#2245; Nefrología
#2309:servicio de neurología
#2351: Servicio de dermatología
#2900; Cardiología
#3411 - Reumatología
#3456: Cardiología
#3850: Hematología
#6004:Oncología
#7004: Oncología Médica
#766; Oncología
#9102: Hematología Clínica
1101: Dermatología
1306: Hematologia y Transfusion
1307: Alliance Member
1400:Dermatología
2752; Dermatología
2802: Reumatología
34005: Oncología Médica
3411: Reumatología
3456: Servicio Dermatología
40890: Dermatologia
6500: Dermatología
7002:reumatología
7003: Oncología Médica
724007: Oncología Médica
9249: Servicio Dermatología
9751; Dermatología
Anaesthesiology
Anaesthesiology and Resucitation
Anestesiología y Reanimación
Anesthesiology
Anesthesiology, Resuscitation and Pain Therapy Department
Cap de Secció d´Hepatologia, Servei de Digestiu
Cardiologia
Cardiology
cirugia
Clinic Hematology
Clinical Hematology
Critical Care Unit
Departamento de Neurología
Department of Infectious Diseases
Department of Urology
Dermathology unit
Dermatología
Dermatology
Dermatology department
Digestive service
Digestología
Endrocrinology
Farmacología Clínica
Gastroenterologia
Gastroenterology
Gastroenterology Unit
General and Digestive System Surgery
General Surgery
Ginecology and Obstetrics
Gynecological Department
Haematology
Heart Failure Unit
Hematología
Hematología Clínica
hematology
Hematology and Hemotherapy
Hematology department
Hepatology Section, Department of Gastroenterology
Hospital de día de infecciosas
Hospital del Mar
Hospital del Mar_Cardiología - Ensayos Clínicos
Hospital Pharmacy
IMIM-Hospital del Mar
Infecciosas
Infectious Disease Unit
Infectious Diseases
Infectious Diseases Department
Infectious Diseases Service
Integrative Pharmacology and Systems Neuroscience research group
Integrative Pharmacology and Systems Neurosciences
Intensive Care Unit
Medical Oncology
Medical Oncology Department
Medicina Interna /Enfermedades Infecciosas
Medicine
N/A
NA
Nefrología
Nefrología y Trasplante Renal
Nefrology
Nephrology
Nephrology and Kidney Transplant
Nephrology and Trasplant
Nephrology Department
Nephrology department, Pg. Marítim de la Barcelona, 25-29, Ciutat Vella, 08003 Barcelona, Spain
Nephrology Service
Neumología
Neumology
Neuro-Oncology
Neurology
Neurology department
Neurology Service
Nuclear Medicine
Obstetricia y Ginecología
Oftalmologia
Oncolgy
Oncologia
Oncología médica
ONCOLOGU
Oncology
Oncology department
Oncology Service
Otorhinolaryngolog Service
Otorhinolaryngology
Otorrinolaringología
Parc de Salut Mar - Hospital del Mar
Pharmacology
Pneumology
Pneumology service
Psiquiatría
Psychiatry
Pulmonology
Research Institute
Reumatología
Rheumatology
Servei de Dermatologia
Servei h'Hematologia Clinica
Servicio de digestivo
Servicio de Angiología y Cirugía vascular
Servicio de Cardiologia
Servicio de Dermatologia
Servicio de Digestología
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Hematologia Clinica
Servicio de Infecciosas
Servicio de Nefrologia
Servicio de Neumología
Servicio de Neurología
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatologia
Servicio de Urologia
Servico de Reumatologia
Thoracic Oncology
Treatment Resistant Schizophrenia and Psychosocial Rehabilitation Unit
Tuberculosis Unit, Service of Infectious Diseases
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de Cancer Genitourinaria
Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva.
Unidad de Insuficiencia Cardiaca
Unidad del Dolor
Unitat de deteriorament cognitiu i transtorns del moviment
URC
Urologia
Urology
Urology-Oncology
Vascular Surgery

Clinical trials at this site (480)

Search interface

Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o… Pending

2025-521632-12-00 Patients on Factor Xa inhibitor treatment needing an ur 5
REstoration with calcifediol of VItamin D deficiency in pulmonary Arterial Hypertension patients (REVIDAH study) Pending

2025-521694-14-00 Patients with diagnosis of Pulmonary Arterial Hypertens 6
Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed sma… Pending

2025-521902-17-00 Unresectable/metastatic Small cell Lung Cancer (SCLC) 9
A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflamma… Pending

2025-522076-85-00 Rheumatoid arthritis 4
STAMPEDE2: A randomised controlled platform trial testing treatments in metastatic hormone sensitive prostate cancer Pending

2025-522145-21-00 Metastatic hormone sensitive prostate cancer 5
A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w… Pending

2025-522542-40-00 Acute Ischemic Stroke 5
An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr… Pending

2025-522983-33-00 Chronic rhinosinusitis with nasal polyps 5
STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN… Pending

2025-523120-53-00 Graft pyelonephritis in kidney transplant recipients 11
A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or… Pending

2025-523461-17-01 LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANC 5
A Study to Learn about the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive Stage Sma… Pending

2025-523522-41-00 Extensive-Stage Small Cell Lung Cancer 10
Symbiotic-GU-06-A Study to Learn About the Study Medicine PF-08634404 Alone or In Combination With Enfortumab Vedotin in Adult Participants … Pending

2025-523523-21-00 Locally Advanced or Metastatic Urothelial Cancer 9
A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Pending

2025-523576-23-00 Unresectable Stage III non-small cell lung cancer witho 5
A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Pending

2025-523586-18-00 Non-Small Cell Lung Cancer 5
SAVE trial Pending

2025-523709-13-00 Acute ischemic stroke 5
Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin… Pending

2025-523922-42-00 recurrent urine infections 6
A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial Pending

2025-524078-40-00 Chronic Spontaneous Urticaria 5
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Pending

2025-524103-69-00 Chronic Venous Insufficiency 10
Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m… Pending

2025-524408-30-01 Metastatic hormone-sensitive prostate cancer 5
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures Recruiting

2025-524038-24-00 Focal Epilepsy 5 2026-05-22
Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting

2025-522107-18-00 Locally advanced or metastatic Non-Small Cell Lung Canc 4 2026-05-19
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS) Recruiting

2025-524002-16-00 Amyotrophic Lateral Sclerosis 5 2026-05-12
Phase 2 EL219 versus Liposomal Amphotericin B for Early Antifungal Therapy Recruiting

2025-522835-32-00 Suspected Invasive Mould Infection 4 2026-05-08
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes. Recruiting

2025-523104-71-00 Obesity or Overweight Without Type 2 Diabetes 5 2026-05-08